Cagrilintide 10mg (Amylin Receptor Agonist)⁠

Cagrilintide Peptide | Amylin & Calcitonin Receptor Agonist

Cagrilintide is a novel, long-acting acylated analog of the pancreatic hormone amylin. By working as a non-selective agonist, it simultaneously targets amylin receptors (AMY) and calcitonin receptors. In laboratory research models, it exhibits a prolonged half-life achieved through targeted fatty acid engineering, allowing investigators to thoroughly study continuous neurochemical satiety triggers and slow-gastric emptying mechanisms without frequent degradation.

Mechanistic & Cellular Target Channels

• Synergistic Hindbrain Signaling: Binds directly to calcitonin receptor core complexes in the area postrema to induce long-term satiation signals in laboratory animal profiles.
• Gastric Motility Regulation: Modulates in vitro gastrointestinal transit speeds to evaluate delay dynamics in nutrient absorption.
• Glucagon Secretion Suppression: Regulates pancreatic alpha-cell pathways to study the secondary suppression of postprandial hepatic glucose output.

Primary Laboratory Research Applications

• Central appetite control, hindbrain neurology, and long-acting satiety modeling.
• Synergistic weight management studies (frequently paired with GLP-1 receptor agonists like Semaglutide).
• Gastric emptying inhibition mechanics and nutrient distribution profiling.
• Pancreatic hormone secretion analysis and insulin/glucagon balancing controls.